Interferon gamma 1a biosimilar - Shionogi

Drug Profile

Interferon gamma 1a biosimilar - Shionogi

Alternative Names: Imunomax; Imunomax-γ; S-6810

Latest Information Update: 22 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shionogi
  • Class Antineoplastics; Antivirals; Interferons; Lymphokines
  • Mechanism of Action Interferon stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mycosis fungoides
  • New Molecular Entity No

Highest Development Phases

  • Marketed Mycosis fungoides; Sezary syndrome

Most Recent Events

  • 01 Jun 2014 Launched for Mycosis fungoides and Sezary syndrome in Japan (IV)
  • 01 May 2014 Registered for Mycosis fungoides and Sezary syndrome in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top